CERELIFE.
Cerebroprotein Hydrolysate
Approved
Registration Information
- Food ID
- 11763
- Status
- Approved
- Application Type
- New/Innovator
- Classification
- Human
Product Information
- Active Ingredient
- Cerebroprotein Hydrolysate
- Strength
- Cerebroprotein Hydrolysate 90 mg
- Dosage Form
- Tablet
- Route of Administration
- Oral
- Packaging
- 30 TABLETS (3 X 10 ALU-ALU PACK)
- Visual Description
- Reddish Colour Tablets
- Shelf Life
- N/A
Manufacturer Information
- Manufacturer / Site
- QUESTA CARE LIMITED
- MAH (Marketing Authorization Holder)
- QUESTA CARE INC., USA
- Country
- Kenya
- Local / Foreign
- Local
Record Information
- Last Fetched
- 2026-02-28 03:41:02
- Last Updated
- 2026-11-04 03:42:00
Important Notice
This information is sourced from the Pharmacy and Poisons Board of Kenya. Always consult with a qualified healthcare professional before using any supplement.